deferoxamine has been researched along with cgp 43902a in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Avramovici-Grisaru, S; Iheanacho, EN; Samuni, A; Sarel, S; Spira, DT | 1 |
| Bergeron, RJ; Evans, KM; Jenny, HB; Luchetta, G; Peter, H; Streiff, RR; Vinson, JR; Wiegand, J | 1 |
2 other study(ies) available for deferoxamine and cgp 43902a
| Article | Year |
|---|---|
Growth inhibition of Plasmodium falciparum involving carbon centered iron-chelate radical (L., X-)-Fe(III) based on pyridoxal-betaine. A novel type of antimalarials active against chloroquine-resistant parasites.
Topics: Animals; Antimalarials; Chloroquine; Deferoxamine; Drug Resistance; Electron Spin Resonance Spectroscopy; Hydrazines; Iron; Iron Chelating Agents; Molecular Structure; Oxidants; Oxidation-Reduction; Plasmodium falciparum; Spectrophotometry | 1991 |
A comparative evaluation of iron clearance models.
Topics: Animals; Bile; Chelating Agents; Deferoxamine; Dihydropyridines; Haplorhini; Hydrazines; Iron; Iron Chelating Agents; Male; Rats; Rats, Inbred Strains; Spectrophotometry, Atomic; Thiazoles | 1990 |